Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2021 | Genomic profiling of Hispanic patients with myeloma

Patrick Blaney • 13 Dec 2021
ASH 2021
Multiple Myeloma
CoMMpass

In this video, Patrick Blaney, MS, Perlmutter Cancer Center, NYU Langone Health, New York, NY, highlights a study which aims to analyze the genomic profile of Hispanic or Latin American patients with multiple myeloma (MM) to see if there are characteristics that can be related to the overall survival (OS) and progression-free survival (PFS) of these patients. Using data from the MMRF CoMMpass study (NCT01454297), Mr Blaney discusses the preliminary results obtained, and the benefit of comparing these findings to other populations. This interview took place at the 63rd ASH Annual Meeting and Exposition congress, Atlanta, GA, 2021.

More from Patrick Blaney

1:25
The importance of identifying and understanding high-risk multiple myeloma
Patrick Blaney • 13 Dec 2021
2:52
The relationship between chromosome 1 abnormalities and poor prognosis in multiple myeloma
Patrick Blaney • 13 Dec 2021

Related Videos

1:47
Looking forward to the Miami Myeloma MRD Virtual Meeting 2024
Ola Landgren • 13 Apr 2024
2:27
The encouraging results of the LINKER-MM1 trial: safety and efficacy of linvoseltamab in R/R myeloma
Faith Davies • 9 Apr 2024
0:37
Upcoming studies investigating linvoseltamab in myeloma
Faith Davies • 9 Apr 2024
3:23
Molecular characteristics associated with increased risk of disease progression in SMM
Mark Bustoros • 27 Sep 2023
The content of VJHemOnc is intended for healthcare professionals